Skip to main content
Clinical Trials/ISRCTN61649292
ISRCTN61649292
Completed
Phase 4

A randomised, double-blind, placebo-controlled trial to investigate the effect of intensified treatment with high dose rifampicin and levofloxacin for adult patients with tuberculous meningitis

niversity of Oxford (UK)0 sites817 target enrollmentOctober 6, 2009

Overview

Phase
Phase 4
Intervention
Not specified
Conditions
Tuberculosis of nervous system
Sponsor
niversity of Oxford (UK)
Enrollment
817
Status
Completed
Last Updated
5 years ago

Overview

Brief Summary

Registry
who.int
Start Date
October 6, 2009
End Date
March 15, 2015
Last Updated
5 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
niversity of Oxford (UK)

Eligibility Criteria

Inclusion Criteria

  • Greater or equal to 15 years of age (either sex) with a clinical diagnosis of tuberculous meningitis

Exclusion Criteria

  • 1\. Positive cerebrospinal fluid (CSF) Gram or India Ink stain
  • 2\. Known or suspected pregnancy
  • 3\. Known hypersensitivity/intolerance to fluoroquinolones or rifampicin
  • 4\. Estimated glomerular filtration rate (GFR) less than 40 ml/min
  • 5\. Laboratory contraindications to antituberculous therapy:
  • 5\.1\. Bilirubin greater than 2\.5 x upper limit of normal (ULN)
  • 5\.2\. Aspartate aminotransferase (AST) or alanine aminotransferase (ALT) greater than 5 x ULN
  • 6\. Lack of consent

Outcomes

Primary Outcomes

Not specified

Similar Trials